Factors affecting return of symptoms 1 year after treatment in a 62-week controlled study of fluoxetine in major depression

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 21, 2001, Pages 16-23

  Reimherr, F W ^a   Strong, R E ^a   Marchant, B K ^a   Hedges, D W ^a   Wender, P H ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; IMIPRAMINE; MILNACIPRAN; MIRTAZAPINE; PAROXETINE; PLACEBO; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; LIFESTYLE; LONG TERM CARE; MALE; MARRIAGE; MENTAL STRESS; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK FACTOR; SOCIAL ADAPTATION; SOCIAL ASPECT; SOCIAL SUPPORT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; CHRONIC DISEASE; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; MARRIAGE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 0034797878     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. An 11-year follow-up study of 110 depressed patients
2. Time to recovery, chronicity, and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects
3. Recurrence after recovery in unipolar major depressive disorder: An observational follow-up study of clinical predictors and somatic treatment as a mediating factor
4. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
5. Long-term outcome of episodes of major depression: Clinical and public health significance
6. Depressive neurosis: A long-term prospective and retrospective follow-up study of former inpatients
7. 12-Month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression)
8. Do psychosocial factors influence outcome in severely depressed female psychiatric in-patients?
9. The time course of nonchronic major depressive disorder: Uniformity across episodes and samples
10. Residual symptoms after partial remission: An important outcome in depression
11. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder
12. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders
13. Lithium carbonate and imipramine in prevention of affective episodes: A comparison in recurrent affective illness
14. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination
15. Three year outcomes for maintenance therapies in recurrent depression
16. Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment
17. The prophylactic efficacy of fluoxetine in unipolar depression
18. Sertraline in the prevention of depression
19. Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial
20. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression
21. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: A placebo-controlled 6 month study
22. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
23. Mirtazapine versus amitriptyline in the long-term treatment of depression: A double-blind placebo-controlled study
24. Prevention of recurrent depressive episodes with milnacipran: Consequences on quality of life
25. Social functioning and residual symptomatology among outpatients who responded to treatment and recovered from major depression
26. Fluoxetine in the prevention of depressive recurrences: A double-blind study
27. The effects of detection and treatment on the outcome of major depression in primary care: A naturalistic study in 15 cities
28. Outcome of depression and anxiety in primary care: A three-wave 3 1/2-year study of psychopathology and disability
29. Characteristics and course of major depression in older primary care patients
30. Social adjustment and depression: A longitudinal study
31. Marital adjustment in major depression
32. Differential changes in areas of social adjustment from depressive episodes through recovery
33. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses
34. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population
35. Social adjustment in dysthymia, double depression and episodic major depression
36. Imipramine and social-vocational adjustment in chronic depression
37. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression
38. Recovery and major depression: Factors associated with twelve-month outcome
39. Depressive relapses and incomplete recovery from index episode
40. Antidepressants: Partial response in chronic depression
41. Double depression: Two-year follow-up
42. Recurrent brief depression: The Zurich study
43. The role of psychosocial and biological variables in separating chronic and non-chronic major depression and early-late-onset dysthymia
44. Recurrent brief depression
45. Predictors of persistent social impairment among recovered depressed outpatients
46. Personality and the prediction of long-term outcome of depression
47. The importance of axis II in patients with major depression: A controlled study
48. Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program
49. Predicting the course of melancholic and nonmelancholic depression: A naturalistic comparison study
50. Is there any specific personality disorder or personality disorder cluster that worsens the short-term treatment outcome of major depression?
51. Marital disputes and treatment outcome in depressed women
52. The impact of an uncaring partner on improvement in non-melancholic depression
53. The Edinburgh primary care depression study: Personality disorder and outcome
54. Life events, social support and marital relationships in the outcome of severe depression
55. Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression
56. The social readjustment rating scale
57. The assessment of social adjustment: A review of techniques
58. Does depression generate negative life events?
59. A case-control study of social risk factors for depression in American patients
60. The course of marital disputes in depressed women: A 48-month follow-up study